Not Signed In -
Stomach |
|
|
Stomach The location of the stomach in the body. Diagram from cancer.gov:* 1. Body of stomach * 2. Fundus * 3. Anterior wall * 4. Greater curvature * 5. Lesser curvature * 6. Cardia * 9. Pyloric sphincter * 10. Pyloric antrum * 11. Pyloric canal * 12. Angular notch * 13. Gastric canal * 14. Rugal folds Work of the United States Government Latin gaster Gray's subject #247 1161 System Precursor {{{Precursor}}} MeSH A03.556.875.875 Dorlands/Elsevier g_03/123860 ...
Wikipedia - [full article]
Stomach Clinical Trials
- Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer
ClinicalTrials.gov Identifier: NCT00201747 - Active, not recruiting
Esophageal Cancer; Esophagus Cancer; Cancer of Stomach; Stomach Cancer
- Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
ClinicalTrials.gov Identifier: NCT00004099 - Active, not recruiting
stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer; intestinal adenocarcinoma of the stomach; ...
- Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer
ClinicalTrials.gov Identifier: NCT00103324 - Active, not recruiting
recurrent gastric cancer; stage III gastric cancer; stage IV gastric cancer; diffuse adenocarcinoma of the stomach; ...
- Assessing Quality of Life of Patients With Stomach Cancer
ClinicalTrials.gov Identifier: NCT00020826 - Active, not recruiting
adenocarcinoma of the stomach; Quality of Life
- Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomach Cancer - A Multi-Centre Prospective Randomized Controlled Trial
ClinicalTrials.gov Identifier: NCT00165048 - Active, not recruiting
Cancer of Stomach
- Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled Trial
ClinicalTrials.gov Identifier: NCT00164892 - Active, not recruiting
Cancer of Stomach
- CLASSIC - Capecitabine and Oxaliplatin Adjuvant Study in Stomach Cancer
ClinicalTrials.gov Identifier: NCT00411229 - Recruiting
Stomach Neoplasms
- Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer
ClinicalTrials.gov Identifier: NCT00103103 - Active, not recruiting
recurrent gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
- Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach
ClinicalTrials.gov Identifier: NCT00075465 - Active, not recruiting
adenocarcinoma of the stomach; stage III gastric cancer; stage IV gastric cancer
- A Phase I Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00446290 - Recruiting
Stomach Cancer
- Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and GEJ
ClinicalTrials.gov Identifier: NCT00525785 - Recruiting
Stomach Cancer; Gastric Cancer
- Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer
ClinicalTrials.gov Identifier: NCT00002783 - Active, not recruiting
stage III gastric cancer; stage II gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
- Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer
ClinicalTrials.gov Identifier: NCT00042510 - Active, not recruiting
Stomach Neoplasms; Esophageal Neoplasms
- Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
ClinicalTrials.gov Identifier: NCT00002615 - Active, not recruiting
stage II gastric cancer; stage III gastric cancer; adenocarcinoma of the stomach
- A Double-Blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium
ClinicalTrials.gov Identifier: NCT00125736 - Recruiting
Stomach Ulcer
- Antineoplaston Therapy in Treating Patients With Stomach Cancer
ClinicalTrials.gov Identifier: NCT00003524 - Active, not recruiting
stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer; adenocarcinoma of the stomach
- Intraperitoneal Floxuridine in Gastric Carcinoma
ClinicalTrials.gov Identifier: NCT00058916 - Recruiting
Stomach Neoplasms
- Neoadjuvant Irinotecan and Cisplatin Followed By Surgical Resection in Treating Patients With Locally Advanced Cancer of the Stomach or Gastroesophageal Junction
ClinicalTrials.gov Identifier: NCT00062374 - Active, not recruiting
adenocarcinoma of the stomach; stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer
- Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction
ClinicalTrials.gov Identifier: NCT00054457 - Active, not recruiting
adenocarcinoma of the stomach; Adenocarcinoma of the Esophagus; stage IV gastric cancer; recurrent gastric cancer; stage IV esophageal cancer; ...
- An International Phase 2 Study Of Su011248 In Patients With Advanced / Metastatic Gastric Cancer Failing Chemotherapy
ClinicalTrials.gov Identifier: NCT00226811 - Recruiting
Stomach Cancer
- Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach
ClinicalTrials.gov Identifier: NCT00020761 - Active, not recruiting
stage IV gastric cancer; recurrent gastric cancer; stage IV esophageal cancer; recurrent esophageal cancer; adenocarcinoma of the stomach; ...
- Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach
ClinicalTrials.gov Identifier: NCT00061932 - Recruiting
adenocarcinoma of the stomach; recurrent gastric cancer; stage III gastric cancer; stage IV gastric cancer
- ILF With/Without Cisplatin for Advanced Gastric Cancer
ClinicalTrials.gov Identifier: NCT00320294 - Active, not recruiting
Stomach Neoplasm
- Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
ClinicalTrials.gov Identifier: NCT00074009 - Active, not recruiting
recurrent gastric cancer; stage III gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
- Omeprazole and Amoxicillin and/or Vitamin and Mineral Supplements and/or Garlic Supplements in Preventing Stomach Cancer in Patients With Precancerous Stomach Lesions
ClinicalTrials.gov Identifier: NCT00134121 - Active, not recruiting
Gastric Cancer; Precancerous Condition
- A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers.
ClinicalTrials.gov Identifier: NCT00177255 - Active, not recruiting
Cancer
- S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery For Locally Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00134095 - Recruiting
adenocarcinoma of the stomach; stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer
- Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway
ClinicalTrials.gov Identifier: NCT00498134 - Active, not recruiting
Stomach Neoplasms
- Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas
ClinicalTrials.gov Identifier: NCT00419627 - Not yet recruiting
Colorectal Neoplasms; Stomach Neoplasms; Pancreatic Neoplasms; Breast Neoplasms; Ovarian Cancer
- A Comparison of SmartPill Capsule with Scintigraphy for Determining Gastric Residence Time
ClinicalTrials.gov Identifier: NCT00128284 - Recruiting
Digestive System Diseases; Gastrointestinal Diseases; Stomach Diseases; Gastroparesis
- An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric Cancer
ClinicalTrials.gov Identifier: NCT00270543 - Not yet recruiting
Stomach Neoplasms
- Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
ClinicalTrials.gov Identifier: NCT00084604 - Active, not recruiting
stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer; adenocarcinoma of the stomach
- Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus
ClinicalTrials.gov Identifier: NCT00005607 - Active, not recruiting
stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
- Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer
ClinicalTrials.gov Identifier: NCT00003298 - Active, not recruiting
stage III gastric cancer; stage IV gastric cancer; stage II gastric cancer; adenocarcinoma of the stomach
- Pharmacogenetics of Gastrointestinal Bleeding
ClinicalTrials.gov Identifier: NCT00190255 - Active, not recruiting
Gastrointestinal Hemorrhage; Stomach Ulcer; Anti-Inflammatory Agents, Non-Steroidal
- Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00002883 - Active, not recruiting
stage I gastric cancer; stage II gastric cancer; stage I esophageal cancer; stage II esophageal cancer; adenocarcinoma of the stomach; ...
- Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00020787 - Active, not recruiting
stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
- Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
ClinicalTrials.gov Identifier: NCT00022139 - Active, not recruiting
stage III gastric cancer; stage II esophageal cancer; stage III esophageal cancer; adenocarcinoma of the stomach; ...
- Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00012363 - Active, not recruiting
stage IV gastric cancer; recurrent gastric cancer; stage IV esophageal cancer; recurrent esophageal cancer; adenocarcinoma of the stomach; ...
- Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery
ClinicalTrials.gov Identifier: NCT00005876 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; ...
- Optical Coherence Tomography of the Gastrointestinal Tract
ClinicalTrials.gov Identifier: NCT00579748 - Active, not recruiting
Barrett's Esophagus With or Without Dysplasia; Patients With Early Esophageal or Gastric Cancer; Patients With Intestinal Metaplasia of the Stomach
- Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer
ClinicalTrials.gov Identifier: NCT00006081 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; stage IV gastric cancer; ...
- BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy
ClinicalTrials.gov Identifier: NCT00017043 - Active, not recruiting
stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
- Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00006038 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage II gastric cancer; stage IV gastric cancer; ...
- Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach
ClinicalTrials.gov Identifier: NCT00003237 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage II gastric cancer; stage II esophageal cancer; ...
- S-1 and Cisplatin or Fluorouracil and Cisplatin in Treating Patients With Locally Advanced or Metastatic Gastric Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00128609 - Recruiting
stage IV gastric cancer; recurrent gastric cancer; adenocarcinoma of the stomach
- Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00004236 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; ...
- Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation
ClinicalTrials.gov Identifier: NCT00154440 - Recruiting
Lymphoma, Mucosa-Associated Lymphoid Tissue; B-cell Non-Hodgkin''y Lymphoma of the stomach, primary gastric
- S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer
ClinicalTrials.gov Identifier: NCT00088816 - Recruiting
stage IV gastric cancer; adenocarcinoma of the stomach
- Docetaxel and Oxaliplatin in Gastric Cancer
ClinicalTrials.gov Identifier: NCT00382720 - Recruiting
Stomach Neoplasms
- Study of Adjuvant Radiochemotherapy for Gastric Cancer
ClinicalTrials.gov Identifier: NCT00188266 - Recruiting
Stomach Neoplasms
- Docetaxel in Locally Advanced Gastric Adenocarcinoma
ClinicalTrials.gov Identifier: NCT00343239 - Recruiting
Stomach Neoplasms
- Docetaxel and Epirubicin in Advanced Gastric Cancer
ClinicalTrials.gov Identifier: NCT00375999 - Recruiting
Stomach Neoplasms
- Role of Routine Nasogastric Decompression After Subtotal Gastrectomy
ClinicalTrials.gov Identifier: NCT00164918 - Recruiting
Cancer of Stomach
- Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer
ClinicalTrials.gov Identifier: NCT00420394 - Recruiting
Stomach Neoplasms
- Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer
ClinicalTrials.gov Identifier: NCT00525005 - Recruiting
Stomach Neoplasms
- Use of MRI for Assessing Stomach Relaxation in Response to a Meal
ClinicalTrials.gov Identifier: NCT00275743 - Recruiting
Dyspepsia; Healthy Volunteers
- A Study Of The Effect Of CJ-023,423 On The Incidence Of Stomach Ulcers
ClinicalTrials.gov Identifier: NCT00392080 - Recruiting
Osteoarthritis
- Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric Cancer
ClinicalTrials.gov Identifier: NCT00384878 - Recruiting
Stomach Neoplasms
- Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer
ClinicalTrials.gov Identifier: NCT00411151 - Recruiting
Adenocarcinoma of Stomach; Barret Esophagus
- Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC
ClinicalTrials.gov Identifier: NCT00510107 - Recruiting
Stomach Neoplasm; Stage IV; Recurrent
- Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients
ClinicalTrials.gov Identifier: NCT00526110 - Recruiting
Gastrointestinal Diseases
- Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric Cancer
ClinicalTrials.gov Identifier: NCT00511446 - Recruiting
Stomach Neoplasms
- Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma
ClinicalTrials.gov Identifier: NCT00515190 - Recruiting
Stomach Neoplasms
- Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00284908 - Active, not recruiting
Esophagitis; Gastroesophageal Reflux; Stomach Ulcer; Duodenal Ulcer
- Endoscopic Stomach and Pouch Reduction in Patients With Weight Regain Following Roux-En-Y Bypass Surgery
ClinicalTrials.gov Identifier: NCT00411489 - Recruiting
Obesity
- A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer
ClinicalTrials.gov Identifier: NCT00512681 - Recruiting
Stomach Neoplasms
- Chlorambucil Compared With No Further Therapy Following Anti- Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach
ClinicalTrials.gov Identifier: NCT00003617 - Active, not recruiting
stage I gastric cancer
- Irinotecan in Treating Patients With Esophageal or Stomach Cancer
ClinicalTrials.gov Identifier: NCT00003748 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; stage II gastric cancer; ...
- Study of S-1 Versus Capecitabine as First-Line Chemotherapy in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer
ClinicalTrials.gov Identifier: NCT00580359 - Recruiting
Stomach Neoplasms
- Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer
ClinicalTrials.gov Identifier: NCT00239551 - Recruiting
Stomach Ulcer
- Second-Line Irinotecan vs. ILF for AGC
ClinicalTrials.gov Identifier: NCT00509964 - Recruiting
Stomach Neoplasm; Metastatic; Second-Line
- Metastatic Gastric Cancer FFCD 03-07
ClinicalTrials.gov Identifier: NCT00374036 - Recruiting
Stomach Cancer; Neoplasm Metastasis
- S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer
ClinicalTrials.gov Identifier: NCT00182611 - Recruiting
Gastric Cancer
- Xelox Avastin for Metastatic Esophagogastric Adenocarcinoma
ClinicalTrials.gov Identifier: NCT00447330 - Recruiting
Esophageal Neoplasms; Stomach Neoplasms; Neoplasm Metastasis
- Trial of Adjuvant Chemotherapy for Gastric Cancer
ClinicalTrials.gov Identifier: NCT00296322 - Recruiting
Stomach Cancer
- Trial of Adjuvant Chemotherapy for Gastric Cancer
ClinicalTrials.gov Identifier: NCT00296335 - Recruiting
Stomach Cancer
- Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stomach Cancer That Can Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00335959 - Recruiting
Gastric Cancer
- Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancer
ClinicalTrials.gov Identifier: NCT00354224 - Recruiting
Gastric Cancer
- Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-Oesophageal Junction
ClinicalTrials.gov Identifier: NCT00374985 - Recruiting
Esophageal Neoplasms; Stomach Neoplasms
- Surgery Plus IPHC to Treat Peritoneal Carcinomatosis
ClinicalTrials.gov Identifier: NCT00454519 - Recruiting
Stomach Neoplasms; Colorectal Neoplasms; Neoplasm Metastasis; Mesothelioma
- Perioperative Nutrition in Upper GI Cancer Surgery
ClinicalTrials.gov Identifier: NCT00560846 - Recruiting
Stomach Neoplasms; Esophageal Neoplasms; Surgical Complications
- Irinotecan in Treating Patients With Advanced Cancer of the Stomach
ClinicalTrials.gov Identifier: NCT00003137 - Completed
stage IV gastric cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; intestinal adenocarcinoma of the stomach; ...
- Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma
ClinicalTrials.gov Identifier: NCT00390416 - Recruiting
Stomach Neoplasms; Esophageal Neoplasms
- Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer
ClinicalTrials.gov Identifier: NCT00477880 - Recruiting
Gastric Cancer; Precancerous/Nonmalignant Condition
- Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer
ClinicalTrials.gov Identifier: NCT00514020 - Recruiting
Gastric Cancer
- Hyperthermia With Chemotherapy to Treat Inoperable or Metastatic Tumors
ClinicalTrials.gov Identifier: NCT00178698 - Recruiting
Melanoma; Head and Neck Neoplasms; Lung Neoplasms; Stomach Neoplasms; Cholangiocarcinoma
- The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients with HIV
ClinicalTrials.gov Identifier: NCT00001034 - Active, not recruiting
Cytomegalovirus Retinitis; HIV Infections; Gastrointestinal Diseases
- Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer
ClinicalTrials.gov Identifier: NCT00217581 - Recruiting
Esophageal Cancer; Gastric Cancer
- Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer
ClinicalTrials.gov Identifier: NCT00040859 - Active, not recruiting
Esophageal Cancer; Gastric Cancer
- Oblimersen, Cisplatin, and Fluorouracil in Treating Patients With Advanced Esophageal, Gastroesophageal Junction, or Stomach Cancer
ClinicalTrials.gov Identifier: NCT00064259 - Active, not recruiting
Esophageal Cancer; Gastric Cancer
- Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer
ClinicalTrials.gov Identifier: NCT00524186 - Recruiting
Esophageal Cancer; Gastric Cancer
- Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
ClinicalTrials.gov Identifier: NCT00002682 - Active, not recruiting
mucosa-associated lymphoid tissue; stage I diffuse small lymphocytic/marginal zone lymphoma
- Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
ClinicalTrials.gov Identifier: NCT00394433 - Recruiting
Esophageal Cancer; Stomach Cancer
- High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00002722 - Active, not recruiting
childhood gastrointestinal cancer; stage III gastric cancer; stage IV gastric cancer
- Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer
ClinicalTrials.gov Identifier: NCT00006389 - Active, not recruiting
stage III gastric cancer; stage IV gastric cancer
- Study of Sunitinib With S-1 and Cisplatin for Gastric Cancer
ClinicalTrials.gov Identifier: NCT00553696 - Not yet recruiting
Stomach Neoplasms
- Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach
ClinicalTrials.gov Identifier: NCT00004233 - Active, not recruiting
Gastric Cancer; Esophageal Cancer; Adenocarcinoma of the Esophagus
- Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00004873 - Active, not recruiting
stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer
- Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00005060 - Active, not recruiting
stage II gastric cancer; stage III gastric cancer
Resources
- Stomach (National Institute of Diabetes and Digestive and Kidney Diseases)
email this page
print this page
bookmark this page
feedback on this page
